Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.COPH.2004.02.001PMID 15140417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

  2003cited by this paper
• The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

  2003cited by this paper
• Increased exhaled 8-isoprostane in childhood asthma.

  2003cited by this paper
• Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways.

  2003cited by this paper
• Systematic assessment of difficult-to-treat asthma

  2003cited by this paper
• Glucocorticoid resistance in inflammatory bowel disease.

  2003cited by this paper
• Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up.

  2003cited by this paper
• A new class of cyclosporin analogues for the treatment of asthma

  2003cited by this paper
• Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma.

  2003cited by this paper
• Allergic rhinitis: systemic inflammation and implications for management.

  2003cited by this paper
• Corticosteroid-insensitive asthma: molecular mechanisms.

  2003cited by this paper
• Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma.

  2003cited by this paper
• Asthma and rhinosinusitis.

  2003cited by this paper
• How Do Corticosteroids Work in Asthma?

  2003cited by this paper
• Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.

  2003cited by this paper
• Is airway remodeling clinically relevant in asthma?

  2003cited by this paper
• Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.

  2003cited by this paper
• Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis

  2003cited by this paper
• Update on glucocorticoid action and resistance.

  2003cited by this paper
• Serum Total Antioxidant Status in Severe Exacerbation of Asthma: Correlation with the Severity of the Disease

  2003cited by this paper
• Severe/fatal asthma.

  2003cited by this paper
• Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways.

  2003cited by this paper
• Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38

  2002cited by this paper
• Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

  2002cited by this paper
• Glucocorticoid resistance - what is known?

  2002cited by this paper
• Expression of c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma.

  2002cited by this paper
• A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance1

  2002cited by this paper
• p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.

  2002cited by this paper
• Asthma Refractory to Glucocorticoids

  2002cited by this paper
• Bronchial inflammation in corticosteroid‐sensitive and corticosteroid‐resistant asthma at baseline and on oral corticosteroid treatment

  2002cited by this paper
• Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters.

  2002cited by this paper
• Critical role of nuclear factor‐κB and stress‐activated protein kinases in steroid unresponsiveness

  2002cited by this paper
• A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients.

  2002cited by this paper
• Biomarkers of some pulmonary diseases in exhaled breath

  2002cited by this paper
• Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection.

  2001cited by this paper
• Evidence for different subgroups of difficult asthma in children

  2001cited by this paper
• The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma.

  2001cited by this paper
• Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

  2000cited by this paper
• Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.

  2000cited by this paper
• Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

  1999cited by this paper
• Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.

  1999cited by this paper
• Difficult asthma.

  1998cited by this paper
• Psychological morbidity and coping skills in patients with brittle and non‐brittle asthma: a case‐control study

  1997cited by this paper
• Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma.

  1990cited by this paper

• Study on Comprehensive Quality Control of Herba Hyssopi Based on Chemical Components and Pharmacological Mechanism Action

  2026cites this paper
• The GLCCI1 rs37973 variant and the efficacy of inhaled corticosteroids in the treatment of asthma: A meta‐analysis

  2023cites this paper
• Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma

  2022cites this paper
• Can the response to a single dose of beclomethasone dipropionate predict the outcome of long‐term treatment in childhood exercise‐induced bronchoconstriction?

  2022cites this paper
• Does Vitamin D Work Synergistically with Anti-Asthmatic Drugs in Airway Remodeling?

  2022cites this paper
• Lung clearance index and steroid response in pediatric severe asthma

  2020cites this paper
• Pediatric Pulmonology

  2020cites this paper
• This Child's Asthma Appears to Be Severe: But Where Actually Is the Severe Problem?

  2020cites this paper
• Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications

  2020cites this paper
• Chrysin-loaded PLGA attenuates OVA-induced allergic asthma by modulating TLR/NF-κB /NLRP3 axis.

  2020cites this paper
• Asthma and Corticosteroid Responses in Childhood and Adult Asthma.

  2019cites this paper
• Effects of genetic polymorphisms in Vitamin D metabolic pathway on Vitamin D level and asthma control in South Indian patients with bronchial asthma

  2019cites this paper
• Natural killer T Cells: A Powerful Via in the Regulation of Non Communicable Chronic Diseases

  2019cites this paper
• Severe Asthma

  2019cites this paper
• Effects of anthraquinones from Cassia occidentalis L. on ovalbumin-induced airways inflammation in a mouse model of allergic asthma.

  2018cites this paper
• The Protective Effects of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-d-Glucoside in the OVA-Induced Asthma Mice Model

  2018cites this paper
• Mitogen‐activated protein kinases as therapeutic targets for asthma

  2017cites this paper
• INVITED REVIEW SERIES: SEEKING INNOVATIVE SOLUTIONS IN SEVERE ASTHMA

  2017cites this paper
• MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase–mediated suppression of histone deacetylase 2

  2017cites this paper
• Asthma therapeutic management : a pharmacoepidemiological approach

  2017cites this paper
• Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach.

  2016cites this paper
• 37 – Refractory Childhood Asthma: Assessment and Management

  2016cites this paper
• The cardiomyocyte protein αT-catenin contributes to asthma through regulating pulmonary vein inflammation.

  2016cites this paper
• Characterization of Immune Response in Corticosteroid-refractory Severe Asthma in Humans and Mice

  2015cites this paper
• Investigation of the mechanisms of respiratory infection-induced lung disease

  2015cites this paper
• Psychopathology in difficult asthma

  2015cites this paper
• Diagnosis of asthma – new theories

  2015cites this paper
• Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the T(H)2 cytokines.

  2015cites this paper
• IFN-γ-induced JAK/STAT, but not NF-κB, signaling pathway is insensitive to glucocorticoid in airway epithelial cells.

  2015cites this paper
• pathway is insensitive to glucocorticoid in airway

  2015cites this paper
• Long‐term benefits of inhaled corticosteroids in asthma: the propensity score method

  2015cites this paper
• The Nitrated Fatty Acid 10-Nitro-Oleate Attenuates Allergic Airway Disease

  2013cites this paper
• The role of viral and bacterial infections in asthma exacerbations and corticosteroid resistance

  2013cites this paper
• Personalised Medicine and Asthma Diagnostics/Management

  2013cites this paper
• Modulation of responses in allergic airways disease by Haemophilus influenzae infection

  2012influential citation
• Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.

  2012cites this paper
• Definition of Severe Refractory Asthma

  2012cites this paper
• Diagnosis of asthma – a new approach

  2012cites this paper
• IL-13, Asthma and Glycosylation in Airway Epithelial Repair

  2012cites this paper
• Novel therapeutic approaches for the treatment of allergic airways disease

  2011cites this paper
• Clinical update on the use of biomarkers of airway inflammation in the management of asthma

  2011cites this paper
• Bone Marrow‐Derived Mesenchymal Stromal Cells Inhibit Th2‐Mediated Allergic Airways Inflammation in Mice

  2011cites this paper
• p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β2 Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma

  2011cites this paper
• Haemophilus influenzae Infection Drives IL-17-Mediated Neutrophilic Allergic Airways Disease

  2011cites this paper
• Nuclear Translocation of the Glucocorticoid Receptor in Fibroblasts of Asthmatic Patients with Nasal Polyposis Insensitive to Glucocorticoid Treatment

  2011influential citation
• Impact of glycosphingolipid accumulation on the immunological system

  2011cites this paper
• Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment.

  2011cites this paper
• Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes.

  2010cites this paper
• PI3K inhibition in inflammation: Toward tailored therapies for specific diseases

  2010cites this paper
• Natural killer T cells regulate the development of asthma

  2009cites this paper
• Asthma phenotypes in adults and clinical implications

  2009cites this paper
• Therapieresistent astma: behandelopties

  2009cites this paper
• Inhaled corticosteroids for asthma: are they all the same?

  2009cites this paper
• Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease

  2009cites this paper
• Severe asthma: approach and management

  2008cites this paper
• Gene Expression Profi le of Ovalbumin- Induced Lung Infl ammation in a Murine Model of Asthma

  2008cites this paper
• Gene expression profile of ovalbumin-induced lung inflammation in a murine model of asthma.

  2008cites this paper
• Regulation of inflammation by airway smooth muscle

  2008cites this paper
• Disease Mechanisms and Cell Biology

  2008cites this paper
• Difficult-to-treat asthma — an uncontrolled disease. Is there any relation to the experience from palliative medicine?

  2007cites this paper
• Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model.

  2007cites this paper
• Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule IκB Kinase Inhibitors

  2007influential citation
• iNKT cells in allergic disease.

  2007cites this paper
• Variable p‐CREB expression depicts different asthma phenotypes

  2007cites this paper
• The respiratory system

  2007cites this paper
• Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt

  2007cites this paper
• Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy

  2007cites this paper
• Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule I (cid:1) B Kinase Inhibitors □ S

  2007influential citation
• Natural Killer T Cells Regulate the Development of Asthma

  2007cites this paper
• DMD # 9043 1 Biotransformation of Fluticasone : In Vitro Characterization

  2006influential citation
• Ability to Control Persistent Asthma in Obese Versus Non-Obese Children Enrolled in an Asthma-Specific Disease Management Program (Breathmobile)

  2006cites this paper
• Asthma: defining of the persistent adult phenotypes.

  2006cites this paper
• A role for natural killer T cells in asthma

  2006cites this paper
• Mode of Glucocorticoid Actions in Airway Disease

  2006cites this paper
• Lipopolysaccharide exposure makes allergic airway inflammation and hyper‐responsiveness less responsive to dexamethasone and inhibition of iNOS

  2006cites this paper
• BIOTRANSFORMATION OF FLUTICASONE: IN VITRO CHARACTERIZATION

  2006cites this paper
• Validation of the Anti-Inflammatory Properties of Small-Molecule IκB Kinase (IKK)-2 Inhibitors by Comparison with Adenoviral-Mediated Delivery of Dominant-Negative IKK1 and IKK2 in Human Airways Smooth Muscle

  2006influential citation
• A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity

  2005cites this paper
• A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

  2005cites this paper
• Transcription factors in asthma and COPD.

  2004cites this paper